ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix

Oncogene

Volumn 25, Issue 28, 2006, Pages 3924-3933

  Hooi, C F ^a   Blancher, C ^a   Qiu, W ^a   Revet, I M ^a   Williams, L H ^a   Ciavarella, M L ^a   Anderson, R L ^a,c   Thompson, E W ^b,c   Connor, A ^b,c   Phillips, W A ^a,c   Campbell, I G ^a,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Breast cancer; Microarray analysis; Prostate cancer; ST7; Tumor suppressor

Indexed keywords

MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEONECTIN; SOMATOMEDIN BINDING PROTEIN 5;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER GROWTH; CARCINOGENICITY; CELL PROLIFERATION; CHROMOSOME 7Q; COLONY FORMATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC STABILITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; SCID MOUSE; ST7 GENE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; GENE EXPRESSION PROFILING; HUMANS; MALE; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 33745590688     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209418     Document Type: Article

References (46)

1. Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P et al. (1996). Cancer Res 56: 3808-3813.
2. Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, Menon PM et al. (2005a). J Biol Chem 280: 36483-36493.
3. Barker TH, Framson P, Puolakkainen PA, Reed M, Funk SE, Sage EH. (2005b). Am J Pathol 166: 923-933.
4. Bieche I, Champeme MH, Matifas F, Hacene K, Callahan R, Lidereau R. (1992). Lancet 339: 139-143.
5. Brekken RA, Puolakkainen P, Graves DC, Workman G, Lubkin SR, Sage EH. (2003). J Clin Invest 111: 487-495.
6. Brown VL, Proby CM, Barnes DM, Kelsell DP. (2002). Br J Cancer 87: 208-211.
7. Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J et al. (2005). Int J Cancer 113: 789-797.
8. Chlenski A, Liu S, Baker LJ, Yang Q, Tian Y, Salwen HR et al. (2004). Cancer Res 64: 7420-7425.
9. Dennis Jr G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC et al. (2003). Genome Biol 4: P3.
10. Dong SM, Sidransky D. (2002). Clin Cancer Res 8: 2939-2941.
11. Hughes KA, Hurlstone AF, Tobias ES, McFarlane R, Black DM. (2001). Nat Genet 29: 380-381.
12. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L et al. (2004). Cancer Res 64: 3037-3045.
13. Kato Y, Tsukuda M, Nagashima Y, Koshika S, Sakai N, Yao M et al. (2005). Int J Oncol 27: 759-768.
14. Katoh M. (2002). Int J Oncol 20: 1247-1253.
15. Koike M, Takeuchi S, Yokota J, Park S, Hatta Y, Miller CW et al. (1997). Genes Chromosomes Cancer 19: 1-5.
16. Koukourakis MI, Giatromanolaki A, Brekken RA, Sivridis E, Gatter KC, Harris AL et al. (2003). Cancer Res 63: 5376-5380.
17. Kruzelock RP, Cuevas BD, Wiener JR, Xu FJ, Yu Y, Cabeza-Arvelaiz Y et al. (2000). Oncogene 19: 6277-6285.
18. Latil A, Cussenot O, Fournier G, Baron JC, Lidereau R. (1995). Clin Cancer Res 1: 1385-1389.
19. Le Bail B, Faouzi S, Boussarie L, Guirouilh J, Blanc JF, Carles J et al. (1999). J Pathol 189: 46-52.
20. Lu C, Xu HM, Ren Q, Ao Y, Wang ZN, Ao X et al. (2003). World J Gastroenterol 9: 2662-2665.
21. Lussier C, Sodek J, Beaulieu JF. (2001). J Cell Biochem 81: 463-476.
22. Moschos SJ, Mantzoros CS. (2002). Oncology 63: 317-332.
23. Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M. (1993). Mol Cell Biol 13: 6036-6043.
24. Pal S, Vishwanath SN, Erdjument-Bromage H, Tempst P, Sif S. (2004). Mol Cell Biol 24: 9630-9645.
25. Palmer RE, Kotsianti A, Cadman B, Boyd T, Gerald W, Haber DA. (2001). Curr Biol 11: 1805-1809.
26. Paoni NF, Feldman MW, Gutierrez LS, Ploplis VA, Castellino FJ. (2003). Physiol Genomics 15: 228-235.
27. Puolakkainen PA, Brekken RA, Muneer S, Sage EH. (2004). Mol Cancer Res 2: 215-224.
28. Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R, Preissner KT. (1997). Biochem J 324: 311-319.
29. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD. (1998). J Exp Med 187: 1965-1975.
30. Shih SC, Robinson GS, Perruzzi CA, Calvo A, Desai K, Green JE et al. (2002). Am J Pathol 161: 35-41.
31. Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI. (1997). Oncogene 15: 2727-2733.
32. Stanhope-Baker P, Kessler PM, Li W, Agarwal ML, Williams BR. (2004). J Biol Chem 279: 33575-33585.
33. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM et al. (1995). Cancer Res 55: 4114-4119.
34. Thomas NA, Choong DY, Jokubaitis VJ, Neville PJ, Campbell IG. (2001). Nat Genet 29: 379-380.
35. Thomas R, True LD, Bassuk JA, Lange PH, Vessella RL. (2000). Clin Cancer Res 6: 1140-1149.
36. Vincent JB, Herbrick JA, Gurling HM, Bolton PF, Roberts W, Scherer SW. (2000). Am J Hum Genet 67: 510-514.
37. Vincent JB, Petek E, Thevarkunnel S, Kolozsvari D, Cheung J, Patel M et al. (2002). Genomics 80: 283-294.
38. Yiu GK, Chan WY, Ng SW, Chan PS, Cheung KK, Berkowitz RS et al. (2001). Am J Pathol 159: 609-622.
39. Zenklusen JC, Bieche I, Lidereau R, Conti CJ. (1994a). Proc Natl Acad Sci USA 91: 12155-12158.
40. Zenklusen JC, Conti CJ, Green ED. (2001). Nat Genet 27: 392-398.
41. Zenklusen JC, Hodges LC, LaCava M, Green ED, Conti CJ. (2000). Oncogene 19: 1729-1733.
42. Zenklusen JC, Oshimura M, Barrett JC, Conti CJ. (1994b). Oncogene 9: 2817-2825.
43. Zenklusen JC, Thompson JC, Klein-Szanto AJ, Conti CJ. (1995a). Cancer Res 55: 1347-1350.
44. Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. (1994c). Cancer Res 54: 6370-6373.
45. Zenklusen JC, Weitzel JN, Ball HG, Conti CJ. (1995b). Oncogene 11: 359-363.
46. Zhang JS, Nelson M, McIver B, Hay ID, Goellner JR, Grant CS et al. (1998). Oncogene 17: 789-793.